Patent · US Active

Preparation of protective antigen

US8440427B2 · kind B2 · utility

0Cited by
4References
35Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 27, 2012
Grant dateMay 14, 2013
Priority date
Expiry dateJun 27, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A polynucleotide sequence is provided comprising a nucleic acid sequence encoding recombinant Protective Antigen (rPA).Also provided are expression vectors and host cells comprising the polynucleotide sequence of the invention, and methods for producing rPA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.